TargetMol

Oxepinac

Product Code:
 
TAR-T67805
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T67805-1mg1mg£263.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T67805-5mg5mg£544.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T67805-10mg10mg£748.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T67805-25mg25mg£1,099.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T67805-50mg50mg£1,460.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T67805-100mg100mg£1,942.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T67805-500mg500mg£3,821.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
oxepinac is an effective and well-tolerated compound for the treatment of painful osteoarthritis. oxepinac has no teratogenic effect on mouse and rabbit fetuses in animal experiments.
CAS:
55689-65-1
Formula:
C16H12O4
Molecular Weight:
268.26
Purity:
0.9988
SMILES:
O=C(O)CC1=CC=C2C(=O)C=3C=CC=CC3COC2=C1

References

Sasaki S. Multi-centered clinical evaluation of oxepinac against peripheral arthropathy particularly osteoarthritis. Arzneimittelforschung. 1978;28(3):462-468. Arauchi T, et al. Teratogenicity study of oxepinac in mice and rabbits. Arzneimittelforschung. 1978;28(3):451-455. Nomura M, et al. Acute, subacute and chronic toxicity of oxepinac. Arzneimittelforschung. 1978;28(3):445-451.